However, a SIGMAR1 polymorphism (rs1800866) that results in a substitution from glutamine (CAG) to proline (CCG) has been associated with an increased risk of major depressive disorder in the Japanese population [16] and bipolar disorder in the Korean population [17]. This evidence concerns the gene SIGMAR1 and major depressive disorder.